Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$2.27B |
| 2 |
Blackrock
BLK
|
+$1.21B |
| 3 |
PG&E
PCG
|
+$1.17B |
| 4 |
Alibaba
BABA
|
+$1.12B |
| 5 |
T-Mobile US
TMUS
|
+$826M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Treasury Bond ETF
GOVT
|
+$1.34B |
| 2 |
Boston Scientific
BSX
|
+$1.26B |
| 3 |
American Express
AXP
|
+$1.23B |
| 4 |
GE Aerospace
GE
|
+$1.1B |
| 5 |
Visa
V
|
+$993M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.88% |
| 2 | Healthcare | 16.37% |
| 3 | Consumer Discretionary | 13.18% |
| 4 | Financials | 11.24% |
| 5 | Communication Services | 10.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Ovid Therapeutics
OVID
$491M
| $13.1M | ﹤0.01% |
1,781,215
-303,685
| -15% | -$1.42M |
|
1677
Sonoco
SON
$5.74B
| $13.1M | ﹤0.01% |
249,587
-261,021
| -51% | -$12.9M |
|
1678
Climb Global Solutions
CLMB
$519M
| $13M | ﹤0.01% |
2,023,928
-622,800
| -24% | -$2.96M |
|
1679
Central Garden & Pet Co
CENT
$2.8B
| $12.9M | ﹤0.01% |
449,484
-69,140
| -13% | -$1.86M |
|
1680
Consolidated Edison
ED
$39.9B
| $12.9M | ﹤0.01% |
179,804
-546,488
| -75% | -$42M |
|
1681
AeroVironment
AVAV
$9.45B
| $12.8M | ﹤0.01% |
160,883
-36,836
| -19% | -$2.37M |
|
1682
International Paper
IP
$22B
| $12.8M | ﹤0.01% |
384,004
-97,610
| -20% | -$3.11M |
|
1683
Karyopharm Therapeutics
KPTI
$48M
| $12.8M | ﹤0.01% |
45,027
-6,260
| -12% | -$1.85M |
|
1684
Check Point Software Technologies
CHKP
$13.1B
| $12.8M | ﹤0.01% |
118,973
-200,301
| -63% | -$21.2M |
|
|
ORAN
1685
DELISTED
Orange
ORAN
| $12.7M | ﹤0.01% |
1,069,532
-346,417
| -24% | -$4.13M |
|
|
ATRS
1686
DELISTED
Antares Pharma, Inc.
ATRS
| $12.7M | ﹤0.01% |
4,621,827
+1,469,190
| +47% | +$4.1M |
|
1687
Cinemark Holdings
CNK
$4.32B
| $12.7M | ﹤0.01% |
1,099,057
-6,153,566
| -85% | -$83.5M |
|
1688
Factset
FDS
$10.2B
| $12.6M | ﹤0.01% |
38,494
+994
| +3% | +$287K |
|
1689
Gaotu Techedu
GOTU
$436M
| $12.6M | ﹤0.01% |
209,910
+209,727
| +114,605% | +$8.31M |
|
1690
FTAI Aviation
FTAI
$22.2B
| $12.6M | ﹤0.01% |
1,134,309
-1,152,043
| -50% | -$10.6M |
|
1691
Viemed Healthcare
VMD
$371M
| $12.6M | ﹤0.01% |
1,312,190
+400,841
| +44% | +$3.12M |
|
1692
Carpenter Technology
CRS
$28.4B
| $12.4M | ﹤0.01% |
511,755
-35,467
| -6% | -$787K |
|
1693
Corbus Pharmaceuticals
CRBP
$190M
| $12.4M | ﹤0.01% |
49,362
+33
| +0.1% | +$6.67K |
|
1694
Nucor
NUE
$62.1B
| $12.4M | ﹤0.01% |
299,191
-77,330
| -21% | -$3.13M |
|
1695
Casella Waste Systems
CWST
$5.69B
| $12.4M | ﹤0.01% |
237,147
-15,417
| -6% | -$736K |
|
1696
Napco Security Technologies
NSSC
$1.48B
| $12.3M | ﹤0.01% |
1,053,430
+17,200
| +2% | +$180K |
|
1697
BioCryst Pharmaceuticals
BCRX
$2.4B
| $12.2M | ﹤0.01% |
2,556,584
| – | – |
|
|
CVLY
1698
DELISTED
Codorus Valley Bancorp Inc
CVLY
| $12.1M | ﹤0.01% |
876,928
+27,665
| +3% | +$369K |
|
1699
Midland States Bancorp
MSBI
$695M
| $12.1M | ﹤0.01% |
810,785
-41,949
| -5% | -$645K |
|
|
BNR
1700
Burning Rock Biotech
BNR
$92.9M
| $12.1M | ﹤0.01% |
+44,805
| New | +$12.3M |
|
Similar funds
Fidelity Investments's Q2 2020 Portfolio in Review
As of Q2 2020, Fidelity Investments held 4,490 positions worth $909B, up 26% from $722B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Fidelity Investments's Q2 2020 filing shows 334 new, 1,365 increased, 1,743 reduced and 502 closed positions. Its largest new stake was Royalty Pharma: 16,356,491 shares worth $743M. The largest sale was iShares US Treasury Bond ETF, an estimated $1.34B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Fidelity Investments's largest Q2 2020 buy was Royalty Pharma: 16,356,491 shares worth $743M.
- Fidelity Investments added most to Regeneron Pharmaceuticals in Q2 2020, an estimated $2.27B increase.
- Fidelity Investments's biggest Q2 2020 reduction was iShares US Treasury Bond ETF, cutting an estimated $1.34B.
- Fidelity Investments fully exited Sprint Corporation in Q2 2020, selling an estimated $225M.
- Fidelity Investments's ten largest holdings make up 28% of its $909B portfolio in Q2 2020.
- Fidelity Investments opened 334 new positions and closed 502 in Q2 2020.
- Fidelity Investments's portfolio value rose 26% quarter-over-quarter to $909B.
Based on Fidelity Investments's 13F filing for Q2 2020, filed 13 Aug 2020.